T
Timothy E. Dribin
Researcher at Cincinnati Children's Hospital Medical Center
Publications - 21
Citations - 338
Timothy E. Dribin is an academic researcher from Cincinnati Children's Hospital Medical Center. The author has contributed to research in topics: Anaphylaxis & Medicine. The author has an hindex of 7, co-authored 13 publications receiving 92 citations. Previous affiliations of Timothy E. Dribin include University of Cincinnati Academic Health Center.
Papers
More filters
Journal ArticleDOI
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach.
Matthew Greenhawt,Elissa M. Abrams,Marcus Shaker,Derek K. Chu,David A. Khan,Cem Akin,Waleed Alqurashi,Peter D. Arkwright,James L. Baldwin,Moshe Ben-Shoshan,Jonathan A. Bernstein,Theresa Bingemann,Katharina Blumchen,Aideen Byrne,Antonio Bognanni,Dianne E. Campbell,Ronna L. Campbell,Zain Chagla,Edmond S. Chan,Jeffrey Chan,Pasquale Comberiati,Timothy E. Dribin,Anne K. Ellis,David Fleischer,Adam T. Fox,Pamela A. Frischmeyer-Guerrerio,Remi Gagnon,Mitchell H. Grayson,Caroline C. Horner,Jonathan Hourihane,Constance H. Katelaris,Harold Kim,John M. Kelso,David M. Lang,Dennis K. Ledford,Michael Levin,Jay A. Lieberman,Richard Loh,Doug Mack,Bruce Mazer,Giselle Mosnaim,Daniel Munblit,S. Shahzad Mustafa,Anil Nanda,John Oppenheimer,Kirsten P Perrett,Allison Ramsey,Matthew A. Rank,Kara Robertson,Javed Sheikh,Jonathan M. Spergel,David R. Stukus,Mimi L.K. Tang,James M. Tracy,Paul Turner,Anna Whalen-Browne,Dana Wallace,Julie Wang,Susan Waserman,John K. Witry,Margitta Worm,Timothy K. Vander Leek,David B.K. Golden +62 more
TL;DR: In this article, a multidisciplinary group of international experts in anaphylaxis composed of allergy, infectious disease, emergency medicine, and front-line clinicians to systematically develop recommendations regarding SARS-CoV-2 vaccine immediate allergic reactions.
Journal ArticleDOI
Severity grading system for acute allergic reactions: A multidisciplinary Delphi study.
Timothy E. Dribin,Timothy E. Dribin,David Schnadower,David Schnadower,Jonathan M. Spergel,Ronna L. Campbell,Marcus Shaker,Mark I. Neuman,Kenneth A. Michelson,Kenneth A. Michelson,Peter Capucilli,Carlos A. Camargo,David C. Brousseau,Susan A. Rudders,Amal Assa'ad,Kimberly A. Risma,Kimberly A. Risma,Mariana Castells,Lynda C. Schneider,Lynda C. Schneider,Julie Wang,Juhee Lee,Rakesh D. Mistry,David Vyles,Michael Pistiner,John K. Witry,Yin Zhang,Hugh A. Sampson +27 more
TL;DR: In this paper, a consensus severity grading system for acute allergic reactions, including anaphylactic and nonanaphylaxis reactions, was developed for use in clinical care and research.
Journal ArticleDOI
Persistent, refractory, and biphasic anaphylaxis: A multidisciplinary Delphi study.
Timothy E. Dribin,Timothy E. Dribin,Hugh A. Sampson,Carlos A. Camargo,David C. Brousseau,Jonathan M. Spergel,Mark I. Neuman,Mark I. Neuman,Marcus Shaker,Marcus Shaker,Ronna L. Campbell,Kenneth A. Michelson,Kenneth A. Michelson,Susan A. Rudders,Susan A. Rudders,Amal Assa'ad,Amal Assa'ad,Kimberly A. Risma,Kimberly A. Risma,Mariana Castells,Lynda C. Schneider,Lynda C. Schneider,Julie Wang,Juhee Lee,Rakesh D. Mistry,David Vyles,Lisa M. Vaughn,Daniel J. Schumacher,Daniel J. Schumacher,John K. Witry,Shiv Viswanathan,Erica M. Page,David Schnadower,David Schnadower +33 more
TL;DR: Dissemination and application of these definitions in clinical care and research will help standardize the terminology used to describe anaphylaxis outcomes, and serve as the foundation for future research, including the development of an anaphlyaxis severity grading system.
Journal ArticleDOI
Trends in emergency care for anaphylaxis.
Journal ArticleDOI
Reducing Hospitalization Rates for Children With Anaphylaxis.
Karen S. Farbman,Kenneth A. Michelson,Mark I. Neuman,Timothy E. Dribin,Lynda C. Schneider,Anne M. Stack +5 more
TL;DR: A quality improvement (QI) intervention was conducted to improve care and reduce hospitalization rates for children with anaphylaxis and sustained the change over 3 years by using a QI initiative that included evidence-based guideline development and implementation.